Breaking News
Get 45% Off 0
Is it finally time to sell Nvidia ahead of earnings?
Read More

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Why Hormel Foods Is A Must-Add Stock To Your Portfolio? By Zacks Investment Research - Feb 26, 2018

The consumer staples sector is often regarded as an abode of defensive stocks. It is one of the most trusted even when economic conditions are not congenial. Thus, adding stocks from this basket...

Zacks Investment Research
Hudson Pacific (HPP) Signs Lease Renewal With Trailer Park By Zacks Investment Research - Feb 26, 2018

Hudson Pacific Properties, Inc. (NYSE:HPP) has announced a major lease renewal in Hollywood with Trailer Park, a full-service agency that specializes in content creation and entertainment marketing....

Zacks Investment Research
Schlumberger And Subsea To Create A New JV, Stocks Rise By Zacks Investment Research - Feb 26, 2018

Schlumberger Limited (NYSE:SLB) recently announced that the company is considering an opportunity to form a joint venture (JV) with Subsea 7 S.A. (OTC:SUBCY) to provide clients with better subsea...

Zacks Investment Research
Valero (VLO) To Acquire UK Storage Facility From SemGroup By Zacks Investment Research - Feb 26, 2018

Valero Energy Corporation (NYSE:VLO) recently announced that its UK-based subsidiary, Valero Logistics UK Ltd, has agreed to acquire the SemLogistics Milford Haven fuel storage facility from...

Zacks Investment Research
What Other Than Organic Growth Drive M&T Bank (MTB) Stock? By Zacks Investment Research - Feb 26, 2018

On Feb 26, we issued an updated research report on M&T Bank Corporation (NYSE:MTB) . The Buffalo, NY-based banking giant’s prospects look encouraging as it continues to display robust...

Zacks Investment Research
Exelixis (EXEL) Q4 Earnings Meet Estimates, Revenues Beat By Zacks Investment Research - Feb 26, 2018

Investors were not much impressed with Exelixis, Inc.’s (NASDAQ:EXEL) fourth-quarter 2017 performance, wherein though the company beat on revenues, its earnings were in line with estimates....

Zacks Investment Research
AES Corp (AES) Beats On Q4 Earnings, Issues '18 Outlook By Zacks Investment Research - Feb 26, 2018

The AES Corporation’s (NYSE:AES) fourth-quarter 2017 adjusted earnings per share of 43 cents surpassed the Zacks Consensus Estimate of 32 cents by 34.4%. Moreover, the bottom line improved...

Zacks Investment Research
Stocks Jump Another 1% By Zacks Investment Research - Feb 26, 2018

It feels like the good old days! In other words, it feels like it did a month ago, before the market dipped into a correction that included a pair of 1000-point plunges for the Dow. Stocks could...

Zacks Investment Research
Brown & Brown To Become Affordable, Stock Split For 2-for-1 By Zacks Investment Research - Feb 26, 2018

Brown & Brown, Inc. (NYSE:BRO) has recently announced its decision to go for a two-for-one stock split of common stock. Shareholders of record as of Mar 14 will get one additional share for each...

Zacks Investment Research
STERIS Focuses On Expanding Core Business, Competition Rife By Zacks Investment Research - Feb 26, 2018

On Feb 26, we issued an updated research report on STERIS plc (NYSE:STE) . The company has been actively trying to expand into adjacent markets and strengthen core business through acquisitions and...

Zacks Investment Research
What's In The Cards For Immune Design (IMDZ) In Q4 Earnings? By Zacks Investment Research - Feb 26, 2018

Immune Design Corp. (NASDAQ:IMDZ) is scheduled to report fourth-quarter 2017 results on Mar 6.Last quarter, the company delivered a positive earnings surprise of 17.46%. Immune Design topped...

Zacks Investment Research
Will Southwestern Energy (SWN) Disappoint In Q4 Earnings? By Zacks Investment Research - Feb 26, 2018

Southwestern Energy Company (NYSE:SWN) is set to report fourth-quarter 2017 results on Mar 2.Last quarter, the company delivered earnings of 6 cents per share which lagged the Zacks Consensus...

Zacks Investment Research
Clovis (CLVS) Q4 Loss Narrower Than Expected, Revenues Miss By Zacks Investment Research - Feb 26, 2018

Clovis Oncology, Inc. (NASDAQ:CLVS) incurred an adjusted loss of $1.27 per share in the fourth quarter of 2017, which was narrower than the year-ago loss of $1.83 per share as well as the Zacks...

Zacks Investment Research
What's In Store For Epizyme (EPZM) This Earnings Season? By Zacks Investment Research - Feb 26, 2018

Epizyme, Inc. (NASDAQ:EPZM) is expected to report fourth-quarter 2017 results on Mar 8, after the closing bell.Last quarter, the company delivered a positive earnings surprise of 3.08%. In fact,...

Zacks Investment Research
American Tower (AMT) Lags On Q4 Earnings, Tops Revenues By Zacks Investment Research - Feb 26, 2018

American Tower (NYSE:AMT) is a real estate investment trust and a leading wireless tower operator. The firm through its subsidiaries owns, operates and develops wireless and broadcast communications...

Continue with Apple
Continue with Google
or
Sign up with Email